4//SEC Filing
Vellanki Avanish 4
Accession 0000899243-21-017111
CIK 0001724979other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 5:01 PM ET
Size
7.7 KB
Accession
0000899243-21-017111
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Conversion
Common Stock
2021-04-27+11,212→ 2,372,541 total - Conversion
Series A Preferred Stock
2021-04-27−12,108→ 0 total→ Common Stock (11,212 underlying)
Holdings
- 138,901(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-1.0799 basis upon the closing of the Issuer's initial public offering and had no expiration date.
Documents
Issuer
Rain Therapeutics Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 5:01 PM ET
- Size
- 7.7 KB